Alpha Tau Medical Ltd. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 8.46M-8.88M-27.27M-33.76M-29.16M-31.75M
Depreciation and Depletion 0.07M0.09M0.78M0.98M1.07M1.10M
Share-based Compensation 0.55M0.60M0.81M6.75M7.93M9.92M
Gains from Investment Securities 0.20M13.26M3.79M3.30M-0.26M
Cash from Operations -6.91M-7.25M-11.81M-23.88M-17.96M-19.78M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.07M0.09M0.03M0.98M1.07M0.01M
Change in Working Capital
Change in Account Payables 0.15M0.11M0.24M0.22M1.14M0.96M
Change in Accured Expenses 0.31M0.62M2.08M-1.21M1.23M0.66M
Other Working Capital Changes 0.51M-0.28M1.89M-1.64M-0.81M-0.79M
Investing Activities
Capital Expenditures 1.29M3.77M2.93M0.90M6.40M2.24M
Change in Acquisitions & Divestments 45.40M66.15M30.28M32.10M191.86M148.19M
Cash from Investing Activities -10.16M-7.82M19.27M-89.94M18.68M20.77M
Financing Activities
Other financing activities -0.95M0.60M0.81M6.75M
Cash from Financing Activities 5.32M29.32M0.11M96.91M5.30M0.03M
Additional items
Exchange Rate Effect -0.02M0.08M0.11M-0.26M-0.05M0.06M
Change in Cash -11.77M14.33M7.68M-17.17M5.97M1.07M
Free Cash Flow -8.20M-11.02M-14.74M-24.78M-24.36M-22.02M
Net Cash Flow -11.75M14.25M7.57M-16.91M6.02M1.01M